Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Stepping onto the exhibit floor at an Annual Meeting poster session is a memorable experience. Row upon row of...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
Each year, the American Association for Cancer Research (AACR) holds Early-career Hill Day, bringing a group of AACR Associate...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
One late summer morning, I recall seeing a petite woman carrying two suitcases near the entrance to a hospital....
Rates of diabetes in the United States are increasing. According to statistics from the Centers for Disease Control and...
As a regular post on this blog, we feature the 10 articles chosen by our editors from all journal...
In just over a month, the Georgia World Congress Center in Atlanta will host the American Association for Cancer...
There has been a rapid expansion of technology in recent years, from artificial intelligence to intensive genetic sequencing to...
Immune-related adverse events (irAEs) is the collective term used to describe the side effects that arise in response to...